Centro de Recursos

Esta sección contiene investigaciones internacionales y puede hacer referencia a indicaciones que no están aprobadas en todas las regiones. Consulte las indicaciones aprobadas localmente antes de su uso.

Filtrado por:

Buscar
Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the
Pulsenmore's CEO, Dr. Elazar Sonnenschein, has been named "Man of the Year" by Yedioth Ahronoth, the most renowned daily publication in Israel. The feature highlighted his achievements, showcasing his leadership
RAMAT GAN, Israel, Jan. 10, 2024 /PRNewswire/ -- Pulsenmore (TASE: PULS), the global leader in self-scan ultrasound technology for home use, proudly announces the approval of its pioneering prenatal care

RAMAT GAN, Israel, Jan. 10, 2024 /PRNewswire/ — Pulsenmore (TASE: PULS), the global leader in self-scan ultrasound technology for home use, proudly announces the approval of its pioneering prenatal care solution by the Brazilian Health

A new handheld, self-scanning ultrasound device that attaches to a smartphone allows pregnant women to see their baby in the womb at any time and in the comfort of their
Discover Israel's thriving innovation ecosystem and the latest technologies on the horizon in this special edition as is takes a deep dive into Israel's remarkable 75-year history of innovation, highlighting

The News Pulse

Le invitamos a mantenerse al día con las más recientes actualizaciones registrándose a nuestro boletín trimestral

Preguntas frecuentes

Preguntas frecuentes